Source: Schizophrenia Research. Unidades: FMRP, FCF
Subjects: METOTREXATO, ESQUIZOFRENIA
ABNT
LIMA, Thaís Santos de Almeida et al. Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation. Schizophrenia Research, v. 284, p. 67–76, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.schres.2025.07.022. Acesso em: 08 out. 2025.APA
Lima, T. S. de A., Zuelli, F. C., Souza, A. J., Colodete, D. A. E., Silva, N. R. da, Verza, F. A., et al. (2025). Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation. Schizophrenia Research, 284, 67–76. doi:10.1016/j.schres.2025.07.022NLM
Lima TS de A, Zuelli FC, Souza AJ, Colodete DAE, Silva NR da, Verza FA, Deakin B, Del Bel EA, Louzada Júnior P, Ben CMD, Guimarães FS, Nakaya HTI, Gomes FV. Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation [Internet]. Schizophrenia Research. 2025 ; 284 67–76.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1016/j.schres.2025.07.022Vancouver
Lima TS de A, Zuelli FC, Souza AJ, Colodete DAE, Silva NR da, Verza FA, Deakin B, Del Bel EA, Louzada Júnior P, Ben CMD, Guimarães FS, Nakaya HTI, Gomes FV. Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation [Internet]. Schizophrenia Research. 2025 ; 284 67–76.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1016/j.schres.2025.07.022